Paxlovid substantially reduced risk of hospitalization, death during Omicron wave
Nirmatrelvir–ritonavir (Paxlovid) significantly reduced the likelihood of hospitalization or death from COVID-19 in people at risk of severe illness, according to new research in Canadian Medical Association Journal (CMAJ).
Feb 13, 2023
0
16